Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000247272 | SCV000320367 | likely benign | Cardiovascular phenotype | 2015-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001582901 | SCV001813063 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002059046 | SCV002368101 | likely benign | Hypertrophic cardiomyopathy 14 | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265715 | SCV002548235 | likely benign | not specified | 2022-05-16 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001582901 | SCV005211379 | likely benign | not provided | criteria provided, single submitter | not provided |